Free Trial

Teleflex (TFX) Competitors

Teleflex logo
$126.90 -1.53 (-1.19%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TFX vs. PODD, HOLX, BAX, GMED, MASI, ITGR, ATEC, ATRC, IART, and OFIX

Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), and Orthofix Medical (OFIX). These companies are all part of the "health care equipment" industry.

Teleflex vs. Its Competitors

Teleflex (NYSE:TFX) and Insulet (NASDAQ:PODD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Teleflex has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, Insulet has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.

In the previous week, Insulet had 11 more articles in the media than Teleflex. MarketBeat recorded 16 mentions for Insulet and 5 mentions for Teleflex. Insulet's average media sentiment score of 1.01 beat Teleflex's score of 0.39 indicating that Insulet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Insulet
9 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Insulet has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$3.04B1.85$69.68M$4.2529.92
Insulet$2.07B10.98$418.30M$3.2998.26

Insulet has a net margin of 10.01% compared to Teleflex's net margin of 6.31%. Insulet's return on equity of 23.78% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex6.31% 15.08% 8.85%
Insulet 10.01%23.78%9.30%

Teleflex currently has a consensus target price of $141.57, indicating a potential upside of 11.35%. Insulet has a consensus target price of $346.83, indicating a potential upside of 7.29%. Given Teleflex's higher probable upside, research analysts plainly believe Teleflex is more favorable than Insulet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
2 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.92
Insulet
0 Sell rating(s)
3 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.85

95.6% of Teleflex shares are owned by institutional investors. 1.4% of Teleflex shares are owned by company insiders. Comparatively, 0.4% of Insulet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Insulet beats Teleflex on 11 of the 16 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFX vs. The Competition

MetricTeleflexMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$5.62B$6.94B$9.08B$21.91B
Dividend Yield1.06%1.16%5.69%3.58%
P/E Ratio29.9227.6186.0129.70
Price / Sales1.85195.34539.2263.33
Price / Cash5.0021.7337.9224.43
Price / Book1.385.4212.944.62
Net Income$69.68M$178.04M$3.30B$1.01B
7 Day Performance1.38%4.96%4.86%-0.08%
1 Month Performance-2.42%12.97%10.02%2.66%
1 Year Performance-45.76%34.11%84.11%14.83%

Teleflex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TFX
Teleflex
4.6242 of 5 stars
$126.91
-1.2%
$141.57
+11.6%
-45.3%$5.61B$3.04B29.8614,100Analyst Forecast
PODD
Insulet
4.6013 of 5 stars
$309.11
-1.0%
$346.83
+12.2%
+37.6%$21.76B$2.07B93.953,900Positive News
Analyst Forecast
HOLX
Hologic
4.7825 of 5 stars
$68.22
+0.5%
$79.38
+16.4%
-14.9%$15.17B$4.03B28.317,063Analyst Upgrade
BAX
Baxter International
4.7662 of 5 stars
$23.88
+2.8%
$30.11
+26.1%
-38.7%$12.26B$10.64B-79.6138,000Analyst Forecast
Options Volume
GMED
Globus Medical
4.9148 of 5 stars
$60.55
+4.3%
$87.64
+44.7%
-13.7%$8.17B$2.52B23.295,300Analyst Forecast
MASI
Masimo
4.3454 of 5 stars
$147.29
+0.8%
$194.60
+32.1%
+9.8%$8.00B$2.09B-17.295,600Analyst Downgrade
ITGR
Integer
3.9618 of 5 stars
$105.21
+2.1%
$139.57
+32.7%
-18.5%$3.68B$1.72B46.3511,000Positive News
Analyst Forecast
ATEC
Alphatec
4.2435 of 5 stars
$13.96
+1.5%
$18.50
+32.5%
+160.6%$2.07B$611.56M-12.35700
ATRC
AtriCure
2.9293 of 5 stars
$34.81
+1.5%
$50.89
+46.2%
+28.4%$1.73B$465.31M-45.211,300Analyst Forecast
IART
Integra LifeSciences
3.722 of 5 stars
$14.80
+5.9%
$18.43
+24.5%
-15.3%$1.15B$1.61B-2.274,396News Coverage
Analyst Forecast
OFIX
Orthofix Medical
3.0399 of 5 stars
$14.61
+2.8%
$21.75
+48.9%
-4.8%$577.01M$799.49M-4.611,616Analyst Forecast

Related Companies and Tools


This page (NYSE:TFX) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners